AngioWaveNet vs ClearRead CT
AI Verdict
Choose AngioWaveNet if…
Choose AngioWaveNet if your cardiac catheterization lab prioritizes enhanced, real-time vessel visualization during interventional procedures. This AI software is ideal for improving the clarity of fluoroscopic angiograms, aiding interventional cardiologists and vascular surgeons in critical decision-making and procedural guidance.
View AngioWaveNet →Choose ClearRead CT if…
Choose ClearRead CT if your radiology department focuses on improving the detection and characterization of pulmonary nodules and assessing coronary artery calcification from CT scans. This AI suite is best for radiologists and pulmonologists seeking to boost diagnostic accuracy, reduce reading times, and streamline the tracking of lung nodules over time.
View ClearRead CT →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AngioWaveNet | ClearRead CT |
|---|---|---|
| Pricing | Pricing options include annual software licensing or subscription-based access, tailored to cath lab volume and hospital needs. custom packages are available. | Contact for pricing |
| Deployment | Cloud-based or on-premise/servers | On-premise (stand-alone server, virtual machine) and Cloud |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
ClearRead CTClearRead CT emphasizes seamless integration into existing PACS workflows with concurrent reading capabilities, eliminating the need for separate applications or logins. AngioWaveNet also integrates well and requires minimal training, but ClearRead CT's detailed description of workflow integration provides a stronger case for superior usability within a radiologist's daily routine.
Clinical Value
ClearRead CTClearRead CT offers specific, quantifiable clinical outcomes such as a 36% reduction in reading time and a 29% reduction in missed actionable nodules, supported by multiple clinical studies and publications. AngioWaveNet focuses on enhancing vessel visualization, which is valuable, but lacks comparable specific metrics on improved diagnostic accuracy or error reduction in the provided information.
Pricing & Value
AngioWaveNetAngioWaveNet provides more transparent pricing options, including annual software licensing or subscription-based access tailored to cath lab volume and hospital needs, with custom packages available. ClearRead CT's pricing information is limited to 'contact for pricing', offering less initial clarity on cost structures.
Enterprise Readiness
ClearRead CTBoth tools are FDA-cleared and offer flexible deployment options. However, ClearRead CT demonstrates stronger enterprise readiness through its ISO27001 re-certification for information security and documented large-scale deployments in major health systems like Cedars-Sinai and the VA, indicating proven scalability and robust security practices.
Innovation
ClearRead CTClearRead CT features patented vessel suppression technology and automated nodule tracking and comparison to prior exams, and was the first FDA-cleared concurrent read device with novel vessel suppression. AngioWaveNet's AI-powered Spatiotemporal Enhancement Processing (STEPu2122) is innovative for angiograms, but ClearRead CT's broader range of unique features and impact on diagnostic workflow gives it an edge.
Support & Docs
ClearRead CTClearRead CT offers a more comprehensive and transparent support structure, including a customer success hotline, FAQs, detailed user manuals, and information on system requirements and workflows. While AngioWaveNet provides onboarding support and resources, ClearRead CT's explicit listing of various support channels and documentation makes its support more accessible.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AngioWaveNet | ClearRead CT |
|---|---|---|
| Tool Name | AngioWaveNet | ClearRead CT |
| Company | Angiowave Imaging | RIVERAIN TECHNOLOGIES |
| Primary Clinical Focus | Enhances fluoroscopic angiograms for improved vessel visualization in cardiac catheterization laboratories. | Enhances pulmonary nodule detection and coronary artery calcification analysis in CT scans for cardiothoracic health. |
| Target Imaging Modality | Fluoroscopic angiograms | CT scans (ungated, non-contrast CTs) |
| Key AI Capabilities | AI-powered Spatiotemporal Enhancement Processing (STEPu2122), improved vessel visualization, post-processing AI for angiographic images, enhances visibility of blood vessels, vascular structures, and anatomical features. | Pulmonary Nodule Detection (solid, part-solid, ground glass), Patented Vessel Suppression (Clear Visual Intelligence), Nodule Characterization and Measurement, Automated Nodule Tracking and Comparison to Prior Exams, Coronary Artery Calcification (CAC) Scoring. |
| Vendor Compatibility | Compatible with any fluoroscopic angiography system (vendor-agnostic). | Vendor-neutral processing (seamless PACS integration). |
Videos
Demos, reviews, and walkthroughs featuring AngioWaveNet and ClearRead CT.